The Leung lab has been awarded a grant from the University of Utah’s Center for Clinical and Translational Science and Program in Personalized Health to identify biomarkers for refractory Clostridium difficile infection.
Clostridium difficile infection (CDI) is the most common hospital-associated infection, responsible for an estimated 14,000 deaths a year in the US. While there are established antibiotic treatment regimens for CDI, up to 25% of treated cases relapse or recur. In collaboration with investigators from ARUP Laboratories and Intermountain Healthcare, we will be using cutting-edge genomic techniques to identify those who are at risk of developing recurrence of disease.
Announcement and details of other recipients here: http://healthcare.utah.edu/publicaffairs/news/2015/06/06-30-15_Precision_Medicine_Grants_Announcement.php